The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of randomized, placebo (PL)-controlled phase II study evaluating efficacy and safety of regorafenib (REG) in patients (pts) with metastatic osteosarcoma (metOS), on behalf of the French Sarcoma Group (FSG) and Unicancer.
 
Florence Duffaud
Honoraria - Bayer; Lilly; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Novartis
Travel, Accommodations, Expenses - PharmaMar
 
Jean-Yves Blay
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Other Relationship - Innate Pharma
 
Olivier Mir
Stock and Other Ownership Interests - Transgene
Honoraria - Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche; SERVIER; Vifor Pharma
Speakers' Bureau - Lilly; Roche
Travel, Accommodations, Expenses - Pfizer; PharmaMar; Roche
 
Pascaline Boudou-Rouquette
Honoraria - Novartis; PharmaMar; Roche
Travel, Accommodations, Expenses - Amgen; Novartis; Pfizer
 
Sophie Piperno-Neumann
No Relationships to Disclose
 
Nicolas Penel
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
 
Emmanuelle Bompas
No Relationships to Disclose
 
Corinne Delcambre
No Relationships to Disclose
 
Elsa Kalbacher
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Antoine Italiano
Consulting or Advisory Role - Bayer; Eisai; Epizyme; Lilly; Novartis; PharmaMar; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; PharmaMar
 
Olivier Collard
No Relationships to Disclose
 
Christine Chevreau
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Ipsen (Inst); Pfizer (Inst)
 
Antoine Thyss
No Relationships to Disclose
 
Nicolas Isambert
Travel, Accommodations, Expenses - AstraZeneca; Celgene; MedImmune; Novartis; PharmaMar; Roche/Genentech
 
Jessy Delaye
No Relationships to Disclose
 
Nicolas De Sousa Carvalho
No Relationships to Disclose
 
Camille Schiffler
No Relationships to Disclose
 
Corinne Bouvier
No Relationships to Disclose
 
Vincent Vidal
No Relationships to Disclose
 
Sylvie Chabaud
No Relationships to Disclose